3rd Annual NASH Europe
October 23 - 25, 2019 - London GBHanson Wade
info@hansonwade.com
Phone:+44 (0)20 3141 8700
Across 3 packed days, join Europe’s NASH stakeholders as they lead directive discussions, share actionable insights and analyse the next 12 months of NASH drug development through a tighter lens. - Address pharma-physician disconnect in Europe with the EMA - Understand considerations from European Health Technology Assessment Bodies when assessing the value of medicines for NASH with NICE - Review regulatory guidance for NASH with compensated cirrhosis with the FDA Join 80+ other NASH drug developers to navigate solutions for these and 10+ other rate limiting factors as the first NASH therapies receive approval.